Dantrolene in Statin-induced Myopathy | MicrobiomeTrials← Back to trialsNCT06966843
Dantrolene in Statin-induced Myopathy
RecruitingPHASE2, PHASE3INTERVENTIONAL
Trial Details
Start: 2027-10Est. Completion: 2029-01
Enrollment target: 23 participants Other microbiome trials you might be interested in
Statin Intolerance
The purpose of this study is to gain insight into the side-effects of statin consumption, and assess the ability of epic…
La Jolla, United StatesCompleted Jul 28, 2021
Statin Adverse ReactionStatin-induced Myopathy
The goal of this observational study is to learn whether statin-related muscle symptoms are linked to problems in fat me…
Riga, LatviaCompleted Oct 9, 2024
Ischemic Stroke or High-risk TIA (ABCD² ≥ 4)
The research team is conducting a randomized, double-blind, placebo-controlled, multicenter clinical study aimed at eval…
Beijing, ChinaEst. completion Dec 1, 2026